{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T03:44:19Z","timestamp":1792035859835,"version":"4.4.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.antiviral.2017.07.017","type":"journal-article","created":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T03:18:26Z","timestamp":1501557506000},"page":"184-196","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Highlights of the 30th International Conference on Antiviral Research"],"prefix":"10.1016","volume":"145","author":[{"given":"Graciela","family":"Andrei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4654-679X","authenticated-orcid":false,"given":"Zlatko","family":"Janeba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aruna","family":"Sampath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis M.","family":"Schang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4255-9094","authenticated-orcid":false,"given":"E. Bart","family":"Tarbet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Anthony","family":"Vere Hodge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3578-3530","authenticated-orcid":false,"given":"Mike","family":"Bray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 A.","family":"Est\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2017.07.017_bib1","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.antiviral.2016.05.014","article-title":"Effect of Vandetanib on Andes virus survival in the hamster model of Hantavirus pulmonary syndrome","volume":"132","author":"Bird","year":"2016","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2017.07.017_bib2","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/ng.2830","article-title":"A genome-wide association study identifies CDHR3 as a susceptibility locus for early childhood asthma with severe exacerbations","volume":"46","author":"Bonnelykke","year":"2014","journal-title":"Nat. Genet."},{"key":"10.1016\/j.antiviral.2017.07.017_bib3","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01706-16","article-title":"RPLP1 and RPLP2 are essential flavivirus host factors that promote early viral protein accumulation","volume":"91","author":"Campos","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2017.07.017_bib4","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1128\/AAC.40.10.2332","article-title":"Pharmacokinetics of (-)-beta-D-2-aminopurine dioxolane and (-)-beta-D-2-amino-6-chloropurine dioxolane and their antiviral metabolite (-)-beta-D-dioxolane guanine in rhesus monkeys","volume":"40","author":"Chen","year":"1996","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2017.07.017_bib5","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1021\/jm990543n","article-title":"Structure-activity relationships of (E)-5-(2-bromovinyl)uracil and related pyrimidine nucleosides as antiviral agents for herpes viruses","volume":"43","author":"Choi","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2017.07.017_bib6","doi-asserted-by":"crossref","first-page":"3949","DOI":"10.1021\/jm050060l","article-title":"Anti-HIV activity of (-)-(2R,4R)-1- (2-hydroxymethyl-1,3-dioxolan-4-yl)-thymine against drug-resistant HIV-1 mutants and studies of its molecular mechanism","volume":"48","author":"Chu","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2017.07.017_bib7","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1073\/pnas.0611681104","article-title":"c-Src protein kinase inhibitors block assembly and maturation of dengue virus","volume":"104","author":"Chu","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2017.07.017_bib8","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.chembiol.2016.03.010","article-title":"GNF-2 inhibits dengue virus by targeting Abl kinases and the viral E protein","volume":"23","author":"Clark","year":"2005","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.antiviral.2017.07.017_bib9","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.chembiol.2016.03.010","article-title":"GNF-2 inhibits dengue virus by targeting Abl kinases and the viral E protein","volume":"23","author":"Clark","year":"2016","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.antiviral.2017.07.017_bib10","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.antiviral.2014.07.007","article-title":"beta-l-1-[5-(E-2-bromovinyl)-2-(hydroxymethyl)-1,3-(dioxolan-4-yl)] uracil (l-BHDU) prevents varicella-zoster virus replication in a SCID-Hu mouse model and does not interfere with 5-fluorouracil catabolism","volume":"110","author":"De","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2017.07.017_bib11","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1146\/annurev-pharmtox-010716-104533","article-title":"Accelerating drug development: antiviral therapies for emerging viruses as a model","volume":"57","author":"Everts","year":"2017","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.antiviral.2017.07.017_bib12","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1007\/s11095-011-0432-7","article-title":"The Alabama Drug Discovery Alliance: a collaborative partnership to facilitate academic drug discovery","volume":"28","author":"Everts","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.antiviral.2017.07.017_bib13","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2217\/fvl-2015-0011","article-title":"Consortia's critical role in developing medical countermeasures for re-emerging viral infections: a USA perspective","volume":"11","author":"Everts","year":"2016","journal-title":"Future Virol."},{"key":"10.1016\/j.antiviral.2017.07.017_bib14","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1128\/AAC.45.1.158-165.2001","article-title":"Mechanism of action of 1-beta-D-2,6-diaminopurine dioxolane, a prodrug of the human immunodeficiency virus type 1 inhibitor 1-beta-D-dioxolane guanosine","volume":"45","author":"Furman","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2017.07.017_bib15","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/S0140-6736(10)61384-0","article-title":"Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial","volume":"376","author":"Gane","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2017.07.017_bib16","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.antiviral.2017.03.024","article-title":"The MEK-inhibitor CI-1040 displays a broad anti-influenza virus activity in\u00a0vitro and provides a prolonged treatment window compared to standard of care in\u00a0vivo","volume":"142","author":"Haasbach","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2017.07.017_bib17","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1086\/656774","article-title":"RG7128 alone or in combination with pegylated interferon-alpha2a and ribavirin prevents hepatitis C virus (HCV) Replication and selection of resistant variants in HCV-infected patients","volume":"202","author":"Le Pogam","year":"2010","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2017.07.017_bib18","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.antiviral.2017.02.014","article-title":"Current therapy for chronic hepatitis C: the role of direct-acting antivirals","volume":"142","author":"Li","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2017.07.017_bib19","doi-asserted-by":"crossref","first-page":"43395","DOI":"10.1038\/srep43395","article-title":"GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses","volume":"7","author":"Lo","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2017.07.017_bib20","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1021\/jm960098l","article-title":"Structure\u2013activity relationships of 1-(2-Deoxy-2-fluoro-beta-L-arabinofuranosyl)pyrimidine nucleosides as anti-hepatitis B virus agents","volume":"39","author":"Ma","year":"1996","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.antiviral.2017.07.017_bib21","doi-asserted-by":"crossref","first-page":"6986","DOI":"10.1073\/pnas.0832193100","article-title":"A ligand-binding pocket in the dengue virus envelope glycoprotein","volume":"100","author":"Modis","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2017.07.017_bib22","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nature02165","article-title":"Structure of the dengue virus envelope protein after membrane fusion","volume":"427","author":"Modis","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.antiviral.2017.07.017_bib23","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1084\/jem.20151984","article-title":"Balance between transmitted HLA preadapted and nonassociated polymorphisms is a major determinant of HIV-1 disease progression","volume":"213","author":"M\u00f3naco","year":"2016","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.antiviral.2017.07.017_bib24","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1053\/jhep.2001.20899","article-title":"Antiviral activity of clevudine [L-FMAU, (1-(2-fluoro-5-methyl-beta, L-arabinofuranosyl) uracil)] against woodchuck hepatitis virus replication and gene expression in chronically infected woodchucks (Marmota monax)","volume":"33","author":"Peek","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2017.07.017_bib25","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.bmcl.2012.11.027","article-title":"2\u2032-Fluoro-6\u2032-methylene-carbocyclic adenosine phosphoramidate (FMCAP) prodrug: in\u00a0vitro anti-HBV activity against the lamivudine-entecavir resistant triple mutant and its mechanism of action","volume":"23","author":"Rawal","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.antiviral.2017.07.017_bib26","doi-asserted-by":"crossref","first-page":"8311","DOI":"10.1021\/jo201492m","article-title":"Synthesis of diastereomerically pure nucleotide phosphoramidates","volume":"76","author":"Ross","year":"2011","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.antiviral.2017.07.017_bib27","doi-asserted-by":"crossref","first-page":"e1002627","DOI":"10.1371\/journal.ppat.1002627","article-title":"Small-molecule inhibitors of dengue-virus entry","volume":"8","author":"Schmidt","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2017.07.017_bib28","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.antiviral.2014.08.009","article-title":"Meeting report: 27th International conference on antiviral research, in Raleigh, NC, USA","volume":"111","author":"Vere Hodge","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2017.07.017_bib29","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.antiviral.2015.09.015","article-title":"Meeting report: 28th international conference on antiviral research in Rome, Italy","volume":"123","author":"Vere Hodge","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2017.07.017_bib30","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.antiviral.2016.10.014","article-title":"Meeting report: 29th international conference on antiviral research in La Jolla, CA, USA","volume":"137","author":"Vere Hodge","year":"2017","journal-title":"Antivir. Res."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354217304576?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354217304576?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,12,3]],"date-time":"2019-12-03T14:53:47Z","timestamp":1575384827000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354217304576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":30,"alternative-id":["S0166354217304576"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2017.07.017","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]}}}